Thus, plasma insulin, which should change during the glucose tolerance test, was not measured in this study, but given that the patients had type 2 diabetes, they will have varying levels of residual insulin production and insulin sensitivity. This evidence concerns the gene INS and type 2 diabetes mellitus.